Elizabeth Bolan

Weill Cornell Graduate School of Medical Sciences 
"Elizabeth Bolan"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kivell B, Uzelac Z, Sundaramurthy S, et al. (2014) Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40
Xu J, Xu M, Bolan E, et al. (2014) Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P. Synapse (New York, N.Y.). 68: 144-52
Zapata A, Kivell B, Han Y, et al. (2007) Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54
Bolan EA, Kivell B, Jaligam V, et al. (2007) D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32
Pan YX, Xu J, Bolan E, et al. (2005) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Molecular Pharmacology. 68: 866-75
Chefer VI, Czyzyk T, Bolan EA, et al. (2005) Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37
Bolan EA, Pan YX, Pasternak GW. (2004) Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm. Synapse (New York, N.Y.). 51: 11-8
Neilan CL, Janvey AJ, Bolan E, et al. (2003) Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide. The Journal of Pharmacology and Experimental Therapeutics. 306: 430-6
Bolan EA, Tallarida RJ, Pasternak GW. (2002) Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 303: 557-62
Pan YX, Bolan E, Pasternak GW. (2002) Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochemical and Biophysical Research Communications. 297: 659-63
See more...